Navigation Links
Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
Date:8/28/2007

New software will provide first real-time analysis of such

infectious-disease outbreaks

SEATTLE, Aug. 28 /PRNewswire/ -- In the first systematic, statistical analysis of its kind, infectious-disease-modeling experts at Fred Hutchinson Cancer Research Center confirm that the avian influenza A (H5N1) virus in 2006 spread between a small number of people within a family in Indonesia. The findings, by biostatistician Ira M. Longini Jr., Ph.D., and colleagues, appear online and will be published in the Sept. 1 print edition of Emerging Infectious Diseases, a journal of the Centers for Disease Control and Prevention.

Co-authors on the paper were biostatisticians M. Elizabeth (Betz) Halloran, M.D., D.Sc., and Yang Yang, Ph.D.; and epidemiologist Jonathan Sugimoto, M.H.S., a pre-doctoral research associate. All are within the Hutchinson Center's Public Health Sciences Division and Vaccine and Infectious Disease Institute.

The researchers based their findings on a cluster of eight flu cases within an extended family in northern Sumatra. Using a computerized disease-transmission model that took into account the number of infected cases, the number of people potentially exposed, the viral-incubation period and other parameters, the researchers produced the first statistical confirmation of humans contracting the disease from each other rather than from infected birds.

The cluster contained a chain of infection that involved a 10-year-old boy who probably caught the virus from his 37-year-old aunt, who had been exposed to dead poultry and chicken feces, the presumed source of infection. The boy then probably passed the virus to his father. The possibility that the boy infected his father was supported by genetic sequencing data. Other person-to-person transmissions in the cluster are backed up with statistical data. All but one of the flu victims died, and all had had sustained close contact with other ill family members prior to getting sick -- a factor considered crucial for transmission of this particular flu strain.

In an attempt to contain the spread of the virus, the local health authorities eventually placed more than 50 surviving relatives and close contacts under voluntary quarantine and all, except for pregnant women and infants, received antiviral medication as a precaution.

"The containment strategy was implemented late in the game, so it could have been just luck that the virus burned out," Longini said. "It went two generations and then just stopped, but it could have gotten out of control. The world really may have dodged a bullet with that one, and the next time we might not be so lucky," he said.

Should a strain of avian flu acquire the ability to cause sustained human-to-human transmission, the results could be catastrophic, Longini said. "If not contained, the outbreak could spread worldwide through the global transportation network faster than the appropriate vaccine supply could be made available. That's why it's so important to ascertain whether human-to-human transmission is happening as well as the virulence of the strain." The researchers estimated the secondary-attack rate of the virus in Indonesia -- the risk of one infected person passing it to another -- to be 29 percent, a level of infectiousness similar to statistical estimates for seasonal influenza A in the United States.

The researchers also aimed their statistical transmission-assessment technology at another large avian-flu cluster in eastern Turkey that in 2006 infected eight people, four of whom died. In this case, the researchers did not find statistical evidence of human-to-human transmission, most likely due to a lack of sufficient data. "There probably was person-to-person spread there as well but we couldn't get all the information we needed for the analysis," Yang said.

The methods and software used in this research led to the development of a software application called TranStat, which will allow first responders to enter, store and perform real-time analysis of data from infectious-disease outbreaks. This tool soon will be available online free of charge via MIDAS, the Models of Infectious Disease Agent Study, which is supported by the National Institute of General Medical Sciences.

"We know the key to preventing a pandemic is early detection, containment and mitigation with antiviral therapy and this tool will enable those on the front lines, such as physicians, epidemiologists and other public-health officials, to carry that out efficiently," Halloran said. "The manuals on how to collect the necessary data are decades old. They are very outdated and incomplete. Often people on the front lines don't know what to do; they don't collect the correct data to assess whether transmission is occurring. TranStat will prompt people to gather precisely the data that needs to be collected to better understand and contain any infectious-disease spread, not just the avian flu," Sugimoto said.

If a smoldering disease cluster does flame out of control, the software also could be used to estimate the important characteristics of the virus -- such as its transmissibility, secondary-attack rate and reproductive number -- which would give public-health officials a better chance at slowing its spread until a vaccine or other effective control measures could be implemented.

Yang and colleagues recently described the basis for the statistical methods used in the research in The Annals of Applied Statistics.

The study was funded and supported by the National Institute of General Medical Sciences MIDAS network and the National Institute of Allergy and Infectious Diseases.

Longini and Halloran also are professors of biostatistics and Sugimoto is a pre-doctoral student in the School of Public Health and Community Medicine at the University of Washington.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.

CONTACT

Kristen Woodward

(206) 667-5095

kwoodwar@fhcrc.org


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017  PMD ... OptiMed Specialty Pharmacy of Kalamazoo, Mich. ... strategic hub service that expedites and streamlines patient and ... Spiro PD 2.0, and wellness management services.  ... medical device used to measure lung function for a ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/9/2017)... ... ... Monday, September 18 th .The Brain Tumor Foundation (BTF) begins a week-long ... BTF,s Mobile MRI Unit – a 70 Ft. ... brings its nationwide initiative, the Road to Early Detection Sponsor-A-City Campaign to ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... , ... Planet Fitness, one of the largest and fastest growing franchisors and ... flagship location in Covington, LA at 401 N. U.S. Highway 190, in January of ... Depot in the Holiday Square shopping center. Its location allows it to serve both ...
(Date:10/12/2017)... ... 12, 2017 , ... Asante, a nationally recognized health system ... their existing home health joint venture through an agreement, effective October 1, 2017, ... venture home health company with Asante, delivering clinically integrated care, for the past ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, ... In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the ... have extremely low property-tax rates, which contributes to the relatively lower cost of ...
Breaking Medicine News(10 mins):